Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Blood|November 21, 2007
The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell deathIsabelle Petit, Matthias A Karajannis, Loic Vincent, et al.Experimental Hematology|February 23, 2016
Chemosensitizing AML cells by targeting bone marrow endothelial cellsRaphael C Bosse, Briana Wasserstrom, Amy Meacham, et al.Medchemcomm|June 18, 2013
An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable CytotoxicityRajendra P Tanpure, Clinton S George, Madhavi Sriram, et al.Journal of Medicinal Chemistry|May 7, 2019
Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin PolymerizationHaichan Niu, Tracy E Strecker, Jeni L Gerberich, et al.Bioorganic & Medicinal Chemistry Letters|December 24, 2016
Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxiaBlake A Winn, Zhe Shi, Graham J Carlson, et al.Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin LG D Kishore Kumar, Gustavo E Chavarria, Amanda K Charlton-Sevcik, et al.European Journal of Medicinal Chemistry|November 22, 2012
Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin LGustavo E Chavarria, Michael R Horsman, Wara M Arispe, et al.Medchemcomm|February 21, 2017
Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin PolymerizationChristine A Herdman, Tracy E Strecker, Rajendra P Tanpure, et al.The Journal of Clinical Investigation|October 15, 2005
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signalingLoïc Vincent, Pouneh Kermani, Lauren M Young, et al.Cancer Research|December 25, 2002
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculaturePeter D Davis, Graeme J Dougherty, David C Blakey, et al.Pageof 5